Consensus development summaries. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D019964:Mood Disorders / Q000517:prevention & control*; D009316:National Institutes of Health (U.S.); D012008:Recurrence; D014481:United States
D000929:Antidepressive Agents, Tricyclic; D008094:Lithium